Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.

Jang HC, Kang SJ, Choi SM, Park KH, Shin JH, Choy HE, Jung SI, Kim HB.

PLoS One. 2012;7(11):e49136. doi: 10.1371/journal.pone.0049136. Epub 2012 Nov 12.

PMID:
23152862
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR.

Clin Infect Dis. 2012 Nov 15;55(10):1329-37. doi: 10.1093/cid/cis717. Epub 2012 Aug 20.

PMID:
22911641
[PubMed - indexed for MEDLINE]
Free Article
3.

Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.

Moise PA, Forrest A, Bayer AS, Xiong YQ, Yeaman MR, Sakoulas G.

J Infect Dis. 2010 Jan 15;201(2):233-40. doi: 10.1086/649429.

PMID:
20001853
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.

Wang JL, Wang JT, Sheng WH, Chen YC, Chang SC.

BMC Infect Dis. 2010 Jun 7;10:159. doi: 10.1186/1471-2334-10-159.

PMID:
20529302
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.

Han JH, Edelstein PH, Lautenbach E.

J Antimicrob Chemother. 2012 Oct;67(10):2346-9. doi: 10.1093/jac/dks255. Epub 2012 Jul 3.

PMID:
22761330
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?

de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD.

Diagn Mol Pathol. 2011 Sep;20(3):184-8. doi: 10.1097/PDM.0b013e318208fc47.

PMID:
21817905
[PubMed - indexed for MEDLINE]
7.

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.

Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.

PMID:
23449272
[PubMed - indexed for MEDLINE]
Free Article
8.

Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.

Park SY, Oh IH, Lee HJ, Ihm CG, Son JS, Lee MS, Kim MN.

Antimicrob Agents Chemother. 2013 Nov;57(11):5536-42. doi: 10.1128/AAC.01137-13. Epub 2013 Aug 26.

PMID:
23979741
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.

Honda H, Doern CD, Michael-Dunne W Jr, Warren DK.

BMC Infect Dis. 2011 Dec 5;11:335. doi: 10.1186/1471-2334-11-335.

PMID:
22142287
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.

Neuner EA, Casabar E, Reichley R, McKinnon PS.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):228-33. doi: 10.1016/j.diagmicrobio.2010.02.026.

PMID:
20542203
[PubMed - indexed for MEDLINE]
11.

Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies.

Moise PA, Smyth DS, Robinson DA, El-Fawal N, McCalla C, Sakoulas G.

J Antimicrob Chemother. 2009 May;63(5):873-6. doi: 10.1093/jac/dkp047. Epub 2009 Mar 3.

PMID:
19261624
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, Forrest A, Lodise TP.

Antimicrob Agents Chemother. 2011 Dec;55(12):5433-7. doi: 10.1128/AAC.00407-11. Epub 2011 Sep 19.

PMID:
21930887
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].

Kızılarslanoğlu MC, Sancak B, Yağcı S, Hasçelik G, Unal S.

Mikrobiyol Bul. 2013 Apr;47(2):199-210. Turkish.

PMID:
23621720
[PubMed - indexed for MEDLINE]
Free Article
14.

Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Seidl K, Chen L, Bayer AS, Hady WA, Kreiswirth BN, Xiong YQ.

Antimicrob Agents Chemother. 2011 Dec;55(12):5631-9. doi: 10.1128/AAC.05251-11. Epub 2011 Oct 3.

PMID:
21968365
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.

Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC.

J Antimicrob Chemother. 2011 Oct;66(10):2386-92. doi: 10.1093/jac/dkr301. Epub 2011 Jul 20.

PMID:
21775337
[PubMed - indexed for MEDLINE]
Free Article
16.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

PMID:
21525024
[PubMed - indexed for MEDLINE]
Free Article
17.

Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.

Lin SY, Chen TC, Chen FJ, Chen YH, Lin YI, Siu LK, Lu PL.

J Microbiol Immunol Infect. 2012 Dec;45(6):435-41. doi: 10.1016/j.jmii.2012.05.004. Epub 2012 Jun 30.

PMID:
22749725
[PubMed - indexed for MEDLINE]
18.

Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Ganga R, Riederer K, Sharma M, Fakih MG, Johnson LB, Shemes S, Khatib R.

J Clin Microbiol. 2009 Mar;47(3):590-5. doi: 10.1128/JCM.00397-08. Epub 2009 Jan 14.

PMID:
19144813
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital.

Strandén AM, Frei R, Adler H, Flückiger U, Widmer AF.

Infection. 2009 Feb;37(1):44-8. doi: 10.1007/s15010-008-7430-7. Epub 2008 Oct 30.

PMID:
18974930
[PubMed - indexed for MEDLINE]
20.

Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.

Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Park KH, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS.

Medicine (Baltimore). 2013 Mar;92(2):98-108. doi: 10.1097/MD.0b013e318289ff1e.

PMID:
23429353
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk